News Summary: New Intact Mass software application on waters_connect enables simplified and significantly faster analysis of biomolecules for mass and purity Intact Mass App is now available as an upgrade for new and installed BioAccord LC-MS systems New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity […]

Biognosys’ TrueSignature™ proteomics panels serve as pharmacodynamic readout for protein degradation in Kymera’s discovery and clinical trial programs ZURICH — Biognosys AG, a leader in next-generation proteomics solutions for drug discovery and development, and Kymera Therapeutics, a clinical-stage biopharmaceutical company advancing targeted protein degradation (TPD), announced today that they are broadly collaborating across preclinical studies and […]

Shimadzu Corporation and the AI startup company Epistra Inc. (Address: Minato City, Tokyo; Representative: Representative Director and CEO Yosuke Ozawa; hereinafter “Epistra”) agreed to jointly develop a solution for optimizing culturing parameters used to cultivate cells. The companies intend to commercialize the solution by 2024. The solution being developed will use a Shimadzu triple quadrupole […]

NEWOMICS ANNOUNCES COLLABORATIONS ON HIGH-THROUGHPUT BIOANALYSIS Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, today announced collaborations with Bruker Corporation, a company with differentiated high-value life science research and diagnostics solutions, on a novel LC-MS platform for drug discovery in the Pharma/Biopharma industry as well as research institutions. The two companies agreed […]

The TrueDiscovery™, TrueTarget™, and TrueSignature™ platforms provide an integrated suite of research services that reveal deep biological insights from early stage discovery to the clinic. ZURICH – Business Wire. Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the launch of its expanded suite of proteomics platforms that provide pharmaceutical and […]

SAN DIEGO — Today, Zef Scientific, Inc. and e-MSion, Inc. announce that they have entered a partnership to provide novel electron capture dissociation (ECD) technology upgrades for Thermo Fisher Scientific’s popular line of Q ExactiveTM orbitrap LCMS systems. The agreement covers sales, marketing, all service aspects from installations to warranty provision, preventive maintenance, and troubleshooting in North America. […]

Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments SAN JOSE, Calif. – Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the […]

Bruker PaSER™ 2022 software now features TIMS DIA-NN processing for dia-PASEF® Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies ~9000 protein groups from 200 ng K562 lysate in just 35 min gradient TIMScore further increases phosphopeptides detection by ~25% CHARLESTON, S.C. — At US HUPO,Bruker Corporation (Nasdaq: BRKR) announced its TIMS DIA-NN […]

Thermo Scientific SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets Langerwehe, Germany – A new collection of caps, vials, inserts, kits, well plates and mats improves analytical performance and sample security for chromatography and mass spectrometry users in routine and research laboratories, across a diverse range of sectors such as […]

SOMERVILLE, Mass. — Trace Matters Scientific today introduced two new technologies, SUPER Mass Spec™ and SPion Link™, both category-defining mass spectrometry technologies enabling a quantum leap in the scientific study of complex clinical samples, such as tissue and blood samples. These technologies will empower scientists by providing exceptional mass spectrometry capabilities, which were highly desired […]